| (-)-Epigallocatechin gallate |
| EGCG |
| 989-51-5 |
| Epigallocatechin gallate |
| Epigallocatechin 3-gallate |
| Tea catechin |
| Epigallocatechin-3-gallate |
| Teavigo |
| Epigallocatechin-3-monogallate |
| (-)-Epigallocatechin-3-o-gallate |
| (-)-epigallocatechin 3-gallate |
| PF-EGCg 90 |
| (-)-Epigallocatechol gallate |
| NVP-XAA 723 |
| CCRIS 3729 |
| (2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxybenzoate |
| Catechin deriv. |
| UNII-BQM438CTEL |
| BQM438CTEL |
| epigallocatechin-3-O-gallate |
| CHEBI:4806 |
| Epigallocatechingallate |
| Epigallocatechin-gallate |
| Epigallocatechol, 3-gallate, (-)- |
| (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate |
| CHEMBL297453 |
| [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate |
| DTXSID1029889 |
| [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 3,4,5-trihydroxybenzoate |
| Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester |
| EGCG cpd |
| (-)-Epigallocatechin Gallate (Standard) |
| (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate |
| Gallic acid, 3-ester with epigallocatechol, (-)- |
| DTXCID80567 |
| (-)-cis-3,3',4',5,5',7-Hexahydroxy-flavane-3-gallate |
| epigallo-catechin gallate |
| (-)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate |
| Benzoic acid, 3,4,5-trihydroxy-, 3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester, (2R-cis)- |
| Benzoic acid, 3,4,5-trihydroxy-,(2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester |
| CAS-989-51-5 |
| SMR000449288 |
| SR-01000759328 |
| (-)-EPIGALLOCATECHIN-3-O-GALLATE (USP-RS) |
| (-)-EPIGALLOCATECHIN-3-O-GALLATE [USP-RS] |
| L-Epigallocatechin gallate |
| Epigallocate |
| Sunphenon |
| EPIGALOCATECHIN GALLATE |
| (-)-EGCG |
| Epigallocic acid |
| Teatannin II |
| 2kdh |
| 3oob |
| 4awm |
| (-)-epigallocatechin 3-O-gallate |
| KDH |
| Epigallocatcchin Gallate |
| Epigallocatechol Gallate |
| Spectrum_000316 |
| SpecPlus_000277 |
| Spectrum2_000168 |
| Spectrum3_000244 |
| Spectrum4_001541 |
| Spectrum5_000102 |
| Galloyl-L-epigallocatechol |
| EGCG [WHO-DD] |
| EGCG [MI] |
| 3-O-Galloylepigallocatechin |
| (-)-Epigallocatechin gallat |
| (-)-Epigallocatehin gallate |
| SCHEMBL35258 |
| BSPBio_001628 |
| epigallocatechin-gallate-(-) |
| KBioGR_002002 |
| KBioSS_000796 |
| SPECTRUM210239 |
| cid_65064 |
| MLS000758300 |
| MLS001424000 |
| DivK1c_006373 |
| SPBio_000035 |
| Epigallocatechin monogallate, B |
| GTPL7002 |
| MEGxp0_001166 |
| (-)-Epigallocatechin-3-gallate |
| ACon1_001054 |
| KBio1_001317 |
| KBio2_000796 |
| KBio2_003364 |
| KBio2_005932 |
| KBio3_001128 |
| HMS2051K21 |
| HMS3649E08 |
| 3-O-Galloyl-(-)-epigallocatechin |
| EPIGALLOCATECHIN 3-O-GALLATE |
| Tox21_201468 |
| Tox21_303457 |
| BDBM50070942 |
| CCG-38378 |
| FR-109 |
| HY-13653R |
| LMPK12030005 |
| MFCD00075940 |
| s2250 |
| AKOS015918182 |
| CS-1258 |
| DB12116 |
| DS-9030 |
| EPIGALLOCATECHIN GALLATE [INCI] |
| MCULE-3341525983 |
| MCULE-7760530136 |
| NC00078 |
| SDCCGMLS-0066550.P001 |
| (-)-Epigallocatechin gallate, >=95% |
| (-)-Epigallocatechin-3-gallate; EGCG |
| NCGC00164319-01 |
| NCGC00164319-02 |
| NCGC00164319-03 |
| NCGC00164319-04 |
| NCGC00164319-06 |
| NCGC00257243-01 |
| NCGC00259019-01 |
| (-)-Epigallocatechin gallate (85% (-)-epigallocatechin gallate, 10% (-)-epigallocatechin, 5% (-)- epicatechin gallate) |
| 1ST40118 |
| AC-34075 |
| BP-30205 |
| HY-13653 |
| CS-0694875 |
| E0694 |
| NS00015163 |
| SW197458-3 |
| C09731 |
| M01719 |
| (-)-Epigallocatechin gallate, >=97.0% (HPLC) |
| (-)-Epigallocatechin gallate, analytical standard |
| A845931 |
| Q393339 |
| SR-01000946601 |
| Q-100914 |
| SR-01000759328-5 |
| SR-01000759328-6 |
| SR-01000946601-1 |
| Epigallocatechin-3-gallate 1000 microg/mL in Acetonitrile |
| (-)-Epigallocatechin gallate, >=80% (HPLC), from green tea |
| Epigallocatechin gallate, primary pharmaceutical reference standard |
| ((2R,3R)-2-(3,4,5-trihydroxyphenyl)-5,7-dihydroxy-chroman-3-yl) 3,4,5-trihydroxybenzoate |
| (-)-Epigallocatechin-3-O-gallate, United States Pharmacopeia (USP) Reference Standard |
| (2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl3,4,5-trihydroxybenzoate |
| [5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 2,3,4-trihydroxybenzoate |
| Epigallocatechin gallate, Pharmaceutical Secondary Standard; Certified Reference Material |
| (-)-cis-3,4-Dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-1(2H)-benzopyran-3-yl Gallate |
| (-)-EPIGALLOCATECHIN GALLATE (85% (-)-EPIGALLOCATECHIN GALLATE, 10% (-)-EPIGALLOCATECHIN, 5% (-)-EPICATECHIN GALLATE) |
| (-)-EPIGALLOCATECHIN-3-O-GALLATE (EGCG) (CONSTITUENT OF POWDERED DECAFFEINATED GREEN TEA EXTRACT) |
| (2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl-3,4,5-trihydroxybenzoate |
| (2R-cis)-3,4-Dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl 3,4,5-Trihydroxybenzoate |
| [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl]3,4,5-trihydroxybenzoate |
| 2041570-28-7 |
| 3,4-Dihydro-5,7-dihydroxy-2R-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3R-yl-3,4,5-trihydroxybenzoate |
Home
search mVOC
Features / Tools
mVOC Literature
Help